If you prefer daily dosing or need the lowest cost, Saxenda remains an option, though its results are substantially lower than the other two
Here is what each dose looks like at 10mg/mL: The advantage here is clear for higher doses
The combination of GI symptoms can feel overwhelming in early weeks
Head-to-Head Comparison The most direct comparison came from the SURMOUNT-5 trial, which evaluated tirzepatide compared to semaglutide in adults with obesity
Merck has made two similarly small development deals with China-based biotechs in recent months: an oncology deal with LaNova Medicines and an immunology pact with Curon Pharmaceutical
Bruzzese L, Rostain J-C, Ne L, Condo J, Mottola G, Adjriou N, Mercier L, Berge-Lefranc J-L, Fromonot J, Kipson N, Lucciano M, Durand-Gorde J-M, Jammes Y, Guieu R, Ruf J, Fenouillet E